New drug trial aims to ease muscle weakness in myasthenia gravis
Disease control
Ongoing
This study tests an experimental drug called DNTH103 in 65 adults with generalized myasthenia gravis, a condition causing muscle weakness. Participants receive either the drug or a placebo to see if it safely improves daily activities like talking, swallowing, and breathing. The …
Phase: PHASE2 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:39 UTC